These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 24200605

  • 1. [Idiopathic inflammatory myopathies from the viewpoint of rheumatologists].
    Gono T, Katsumata Y, Kawaguchi Y.
    Brain Nerve; 2013 Nov; 65(11):1275-82. PubMed ID: 24200605
    [Abstract] [Full Text] [Related]

  • 2. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [Abstract] [Full Text] [Related]

  • 3. Management of Myositis-Associated Interstitial Lung Disease.
    Fujisawa T.
    Medicina (Kaunas); 2021 Apr 03; 57(4):. PubMed ID: 33916864
    [Abstract] [Full Text] [Related]

  • 4. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
    Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T.
    Autoimmunity; 2006 May 03; 39(3):233-41. PubMed ID: 16769657
    [Abstract] [Full Text] [Related]

  • 5. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.
    Respir Med; 2017 Jun 03; 127():57-64. PubMed ID: 28461123
    [Abstract] [Full Text] [Related]

  • 6. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
    Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK.
    Clin Rev Allergy Immunol; 2017 Feb 03; 52(1):1-19. PubMed ID: 26424665
    [Abstract] [Full Text] [Related]

  • 7. [The clinical significance of myositis-specific antibodies in polymyositis/dermatomyositis associated interstitial lung diseases].
    Xie MM, Yan X, Li H, Ding JJ, Gui XH, Liu Y, Wang YS, Chen ZY, Cai HR.
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Aug 12; 41(8):616-621. PubMed ID: 30138971
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
    Gono T, Kaneko H, Kawaguchi Y, Hanaoka M, Kataoka S, Kuwana M, Takagi K, Ichida H, Katsumata Y, Ota Y, Kawasumi H, Yamanaka H.
    Rheumatology (Oxford); 2014 Dec 12; 53(12):2196-203. PubMed ID: 24970922
    [Abstract] [Full Text] [Related]

  • 12. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T.
    Respir Investig; 2017 Jan 12; 55(1):24-32. PubMed ID: 28012490
    [Abstract] [Full Text] [Related]

  • 13. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN, Pérez N, Braillard Poccard A, Gómez RA, Costi AC, García MA, Viola M, Benitez A, Aciar MM, Crespo Espíndola M, Yucra D, Cosatti MA, Pisoni C, Capelusnik D, Lojo MN, Barrios BI, Rivero M, Kisluk B, Granel A.
    Clin Rheumatol; 2021 Nov 12; 40(11):4473-4483. PubMed ID: 34159491
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
    Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F.
    Br J Dermatol; 2010 Feb 01; 162(2):337-44. PubMed ID: 19845665
    [Abstract] [Full Text] [Related]

  • 15. [Myositis-specific autoantibodies].
    Fujimoto M.
    Brain Nerve; 2013 Apr 01; 65(4):449-60. PubMed ID: 23568993
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pulmonary manifestations of polymyositis/dermatomyositis.
    Hallowell RW, Ascherman DP, Danoff SK.
    Semin Respir Crit Care Med; 2014 Apr 01; 35(2):239-48. PubMed ID: 24668538
    [Abstract] [Full Text] [Related]

  • 18. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV.
    Arthritis Rheum; 2005 Aug 01; 52(8):2439-46. PubMed ID: 16052580
    [Abstract] [Full Text] [Related]

  • 19. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls.
    Labirua A, Lundberg IE.
    Curr Opin Rheumatol; 2010 Nov 01; 22(6):633-8. PubMed ID: 20827201
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.